Truly independent research?

BMJ

Volumn 337, Issue 7670, 2008, Pages 602-606

  Lenzer, Jeanne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; FLUOXETINE; IBUPROFEN; NAPROXEN; PLACEBO; PSYCHOSTIMULANT AGENT; ROFECOXIB; ROSIGLITAZONE;

CLINICAL TRIAL; CONFLICT OF INTEREST; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; MARKETING; MEDICAL RESEARCH; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; SCIENTIFIC MISCONDUCT; TOBACCO INDUSTRY;

EID: 51949086372     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Harris Interactive. 9th annual RQ: interactive survey of 60 most visible companies. 2007. www.harrisinteractive.com/news/mediaaccess/2008/ HI_BSC_REPORT_AnnualRQ_USASummary07-08.pdf.
2. Rettig RA. The industrialization of clinical research. Health Aff (Millwood) 2000;19:129-46.
3. Mirowski P, Van Horn R. The contract research organization and the commercialization of scientific research. Soc Stud Sci 2005;35:503-48.
4. Lustgarten A. Drug testing goes offshore. Fortune 2005 Aug 8. http://money.cnn.com/magazines/fortune/fortune_archive/2005/08/08/8267653/index. htm.
5. Lenzer J. Researcher to be sacked after reporting high rates of ADHD. BMJ 2005;330:691.
6. LeFever G, Arcona AP, Antonuccio DO. ADHD among American schoolchildren: evidence of overdiagnosis and overuse of medication. Sci Rev Mental Health Practice 2003. [Issue was not published until 2004.] www.srmhp.org/0201/ adhd.html.
7. Monarch. ADHD studies 2005. http://web.archive.org/web/20051124104903/ http://www.monarchresearch.com/Studies/Child/add_adhd.asp.
8. Monarch. Monarch sponsors, 24 November 2005. http://web.archive. org/web/20051124105529/ http://www.monarchresearch.com/Sponsors.asp
9. Shuchman M. Commercializing clinicat trials - risks and benefits of the CRO boom. N Engl J Med 2007;357:1365-8.
10. CenterWatch. State of the clinical trials industry 2008. Boston: CenterWatch, 2008.
11. Breitmeyer J. Reclaiming our province: the role of academic medical centers in clinical trials. Reporter 2000;9(13). www.aamc.org/newsroom/ reporter/oct2000/trials.htm.
12. Harrill SM, Boswick JM, Crouch TJ, Cahillane G, Watson H, Meloy SM. Incorporating affiliates and contract research organizations into global clinical trials. Drug Inf J 1999;33:1033-52.
13. ClinicalTrials.gov. Prospective randomized evaluation of celecoxib integrated safety vs ibuprofen or naproxen (PRECISION). July 2008. http://clinicaltrials.gov/ct2/show/NCT00346216?term=PRECISION+celecoxib& rank=1&show_locs=Y#locn.
14. Solomon SD, Wittes J, Finn PV, Fowler R, Viner J, Bertagnolli MM, et al. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation 2008;117:2104-13.
15. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006;355:873-84.
16. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA 2004;292:807-20.
17. Association of Clinical Research Organizations. Company profile: Quintiles Transnational. 2008, www.acrohealth.org/members-profile.php?id=10.